|
⚲
|
| Keyboard |
| Gansler Jayne M
✚
|
|
|---|---|
| CIK # | 0001676449 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001676449] | |
| 4 | [0001676449] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Ariad Pharmaceuticals Inc | |
| Gansler Jayne M |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Ariad Pharmaceuticals Inc ARIA
Restricted Stock Units · derivative
|
2017-02-16 | Disposed to issuer | 2,910 | $0.00 | |
|
Ariad Pharmaceuticals Inc ARIA
Employee Stock Option (Right to Buy) · derivative
|
2017-02-16 | Disposed to issuer | 144,000 | $0.00 | |
|
Ariad Pharmaceuticals Inc ARIA
Restricted Stock Units · derivative
|
2017-02-16 | Disposed to issuer | 72,000 | $0.00 | |
|
Ariad Pharmaceuticals Inc ARIA
Restricted Stock Units · derivative
|
2017-02-06 | Grant | 2,910 | $0.00 | |
|
Ariad Pharmaceuticals Inc ARIA
Restricted Stock Units · derivative
|
2016-06-06 | Grant | 72,000 | $0.00 | |
|
Ariad Pharmaceuticals Inc ARIA
Employee Stock Option (Right to Buy) · derivative
|
2016-06-06 | Grant | 144,000 | $8.86 | 1,275,840 |